Allogene Therapeutics, Inc. (ALLO) Tops Q1 EPS by 1c

Allogene Therapeutics, Inc. (NASDAQ: ALLO) reported Q1 EPS of ($0.18), $0.01 better than the analyst estimate of ($0.19).

For earnings history and earnings-related data on Allogene Therapeutics, Inc. (ALLO) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Morgan Stanley Resumes OMV AG (OMV:AV) (OMVKY) at Equalweight
• RBC Capital Downgrades Bucher Industries AG (BUCN:SW) (BCHHF) to Sector Perform